• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchADICET Bio
    Picture of ADICET Bio logo

    ACET — ADICET Bio News Story

    $3.990.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapNeutral
    • Market Cap
      $37.35m
    • Enterprise Value
      -$80.04m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ACET Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ACET Dividends
    All News

    NASDAQ RESUMED AT 09:35 AM

    Picture of ADICET Bio logoADICET Bio
    28/09/2026 14:35
    NASDAQ RESUMED  AT 09:35 AM

    Recent news on ADICET Bio

    See all news
    • NASDAQ RESUMED AT 09:35 AM

      28/09/2026 14:35
    • NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM

      28/09/2026 14:30
    • Brief: Adicet Bio Announces Positive Safety And Efficacy Data From Prula-Cel (Formerly Adi-001) Study In Patients With Systemic Lupus Erythematosus With Or Without Lupus Nephritis

      28/09/2026 11:46
    • Brief: Adicet Bio Announces FDA Clearance Of Ind Application For Adi-212

      27/08/2026 21:32
    • Adicet Bio, Inc. Reports Results For The Quarter Ended June 30: Earnings Summary

      05/08/2026 23:49

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.